To determine whether the growth reduction of ESCC cells observed upon treatment of Arbidol depended on the expression of ATR, we performed a proliferation assay using ATR KD cells treated with various concentrations (0, 2.5, 5, 10 and 20 μM) of Arbidol. This evidence concerns the gene ATR and esophageal squamous cell carcinoma.